Bot MD

Cover Block

Public sources

Item	Detail
Name	Bot MD
Tagline	AI clinical assistant integrating hospital systems for doctors [Crunchbase]
Headquarters	Singapore
Founded	2018 [Perplexity Sonar]
Stage	Series A
Business Model	SaaS
Industry	Healthtech
Technology	AI / Machine Learning
Geography	Southeast Asia
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	Series A (total disclosed ~$5,000,000)
Total Disclosed Funding	$5,000,000 [TechCrunch, Feb 2021]

Links

Public sources

• Website: https://www.botmd.io/
• LinkedIn: https://sg.linkedin.com/company/botmd
• Bot MD Care: https://care.botmd.com/

Executive Summary

Public sources

Bot MD is a Series A healthtech startup that has built a smartphone-based AI assistant to help doctors in Southeast Asia and emerging markets access clinical information and automate patient workflows [Perplexity Sonar]. Founded in 2018 by Dorothea Koh and Yan Chuan Sim, the company was part of Y Combinator's summer batch that year [Crunchbase]. The core product integrates hospital-specific protocols, drug formularies, and lab catalogues into a single chat interface [Crunchbase]. A second product, Bot MD Care, launched in 2020 to automate patient engagement and monitoring through messaging apps [LinkedIn - Amin Fariha].

The company raised a $5 million Series A in February 2021 led by Monk's Hill Ventures, with participation from SeaX and SGInnovate [TechCrunch, Feb 2021]. Public traction claims include usage by more than 20,000 doctors and over 100,000 patients [Tatler Asia]. Investors should watch for evidence of commercial scaling, specifically named enterprise customer announcements and updated metrics on revenue and patient reach.

Data Accuracy: YELLOW -- Key traction metrics are sourced from the company or regional press without recent independent corroboration; funding details are confirmed.

Taxonomy Snapshot

Axis	Classification
Stage	Series A
Business Model	SaaS
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	Southeast Asia
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding	Series A (total disclosed ~$5,000,000)

How the Company Got Here

Public sources

Bot MD was founded in Singapore in June 2018 by Dorothea Koh and Yan Chuan Sim to streamline clinical information access [Perplexity Sonar]. The company was accepted into the Y Combinator accelerator program later that year [Perplexity Sonar, Stanford Medicine].

The company's primary milestone was a $5 million Series A funding round in February 2021, led by Monk's Hill Ventures with participation from SeaX, XA Network, and SGInnovate [TechCrunch, Feb 2021]. Post-funding, Bot MD launched its patient engagement platform, Bot MD Care, and reported deployments including Singapore's Tan Tock Seng Hospital [Bot MD news]. The company reports its platform is used by more than 20,000 doctors and nurses globally [Tatler Asia].

Headquartered in Singapore, Bot MD operates as a private company with a reported headcount of 27 employees [ZoomInfo].

Data Accuracy: YELLOW -- Founding and funding details are confirmed by multiple sources; later traction and headcount figures rely on single-source or company-reported data.

Product and Technology

Sources and analysis

Bot MD's platform operates as a clinical interface layer, connecting hospital information systems to a conversational front-end. The core product is a smartphone-based AI assistant that allows doctors to query integrated hospital protocols, drug formularies, and lab catalogues [Perplexity Sonar]. Bot MD Care, launched in 2020, automates workflows like appointment scheduling and follow-up monitoring via messaging apps [LinkedIn - Amin Fariha]. The company states this automation can boost hospital revenue by 20-30% [Perplexity Sonar].

The technology wedge is a proprietary Natural Language Processing chat engine, built by co-founder and CTO Yan Chuan Sim, trained on data from hospital partners and professional medical databases [Perplexity Sonar].

Data Accuracy: YELLOW -- Product claims are primarily sourced from the company's own materials and a secondary analysis; specific technical details and independent performance benchmarks are not available.

Market Research and Opportunity

Public sources

The core opportunity for Bot MD is anchored in a global deficit of clinical capacity. The company's focus on Southeast Asia places it at the intersection of a chronic shortage of healthcare professionals and rapid digital adoption [WHO]. The digital health sector in Asia Pacific was valued at approximately $45 billion in 2022 and is projected to grow at a compound annual rate of over 20% through 2030 [Precedence Research, 2023].

Bot MD's claim that its platform can boost hospital revenue by 20-30% through workflow automation addresses the financial pressure on hospital administrators [Perplexity Sonar]. Regulatory forces are a double-edged sword; while data privacy regulations like Singapore's PDPA impose strict requirements, government initiatives to modernize public health systems act as a tailwind.

Data Accuracy: YELLOW -- Market sizing is inferred from analogous reports; demand drivers are supported by company claims and general regional analysis.

Competitive Landscape

Sources and analysis

Bot MD operates in a fragmented competitive space. The competitive map segments into three layers: large-scale hospital information system (HIS) vendors, clinical decision support (CDS) tools, and regional healthtech startups.

Bot MD's defensible edge rests on its proprietary integration layer and hospital-specific training data [Perplexity Sonar]. The platform's AI chat engine is trained on internal hospital documents, protocols, rosters, and drug formularies. The company is exposed to distribution bottlenecks into large hospital systems and potential substitutes like generic secure messaging platforms.

Data Accuracy: YELLOW -- Competitive positioning is inferred from product claims and market context; specific competitor intelligence is limited.

Opportunity

Public sources

If Bot MD can successfully embed its AI assistant as the primary workflow layer for clinical staff, it could become the region's de facto operating system for patient engagement and clinical decision support. The company has demonstrated its core integration capability at Singapore's Tan Tock Seng Hospital, powering instant information search for 1,000 doctors and nurses [Bot MD news].

Scenario	What happens	Catalyst	Why it's plausible
Protocol Standardization	Bot MD's integrated clinical guidelines become the default reference for major hospital chains.	A partnership with a national medical association establishes the platform as a sanctioned tool.	The company's training data already incorporates professional medical resources and hospital-specific protocols [Perplexity Sonar].
Vertical SaaS Expansion	The company evolves into a full-stack patient relationship management (PRM) system.	The success of the Bot MD Care platform proves the model for scalable, condition-specific engagement.	The product already automates scheduling and GP referrals, demonstrating monetization beyond the initial search utility [Bot MD case studies].

Data Accuracy: YELLOW -- Key growth claims are sourced from the company or regional press; third-party verification is limited.

Sources

Public sources

1. [Crunchbase] Bot MD - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/botmd

2. [TechCrunch, Feb 2021] Bot MD, an AI-based chatbot for doctors, raises $5 million... | https://techcrunch.com/2021/02/02/bot-md-an-ai-based-chatbot-for-doctors-raises-5-million-for-expansion-into-more-asian-markets/

3. [LinkedIn - Amin Fariha] LinkedIn profile of Amin Fariha | https://www.linkedin.com/in/amin-fariha-990024131/

4. [ZoomInfo] Bot MD: Employee Directory | https://www.zoominfo.com/pic/bot-md/471043787

5. [Tatler Asia] Bot MD partners Indonesian Medical Association to provide AI chat assistant to over 200,000 doctors | https://www.tatlerasia.com/gen-t/innovation/singapores-bot-md-to-provide-ai-chat-assistant-to-over-200000-doctors-in-indonesia

6. [Stanford Medicine] Bot MD | Stanford Mussallem Center for Biodesign | https://med.stanford.edu/biodesign/our-impact/technologies/bot-md.html